Search

Search Results

• 

  Typing TREX1 gene in patients with systemic lupus erythematosus

  M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani

  1-7

  30-06-2015

  https://doi.org/10.4081/reumatismo.2015.782

  3635

  PDF: 1908
• 

  Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

  F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

  208-214

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.756

  2981

  PDF: 1629
• 

  Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

  I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula

  1-3

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.1

  2426

  PDF: 830
• 

  Psoriatic arthritis: treatment strategies using biologic agents

  S. D'Angelo, C. Palazzi, I. Olivieri

  113-121

  05-06-2012

  https://doi.org/10.4081/reumatismo.2012.113

  1486

  PDF: 1235

• Pain patterns in italian patients with osteoarthritis: preliminary results of the MI.D.A. Study (Misurazione del Dolore nell’Artrosi)

  M.A. Cimmino, F. Salaffi, I. Olivieri, F. Trotta, P. Sarzi Puttini, W. Grassi, V. Modena, F.P. Cantatore, S. Bombardieri, S. Adami, L. Punzi, G. Lapadula, Gruppo MI.D.A.

  253-261

  https://doi.org/10.4081/reumatismo.2004.253

  2599

  PDF: 6524

• Recommendations for the appropriate use of anti-TNFα therapy in patients with psoriatic arthritis

  C. Salvarani, I. Olivieri, F. Cantini, A. Marchesoni, L. Punzi, R. Scarpa, M. Matucci Cerinic

  133-138

  https://doi.org/10.4081/reumatismo.2004.133

  1632

  PDF: 980

• Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience

  F. Giorgetti, M.L. Minnucci, P. Santori, L. Ercoli, M. Rossi, M. Del Papa, G. Morico, P. Squadroni, A. Olivieri, R. Centurioni

  51-56

  https://doi.org/10.4081/reumatismo.2004.51

  1327

  PDF: 1204

• Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

  S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi

  107-112

  https://doi.org/10.4081/reumatismo.2010.107

  1426

  PDF: 794

• Recommendations for starting anti TNF-α in patients with ankylosing spondylitis

  L. Olivieri, C. Salvarani, F. Cantini, L. Punzi, M. Matucci Cerinic

  220-223

  https://doi.org/10.4081/reumatismo.2003.220

  1588

  PDF: 769

• Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients

  S. Cuffaro, T. Del Ross, M. Tonello, A. Bontadi, S. Olivieri, E. Salvan, A. Ruffatti, L. Punzi

  51-59

  https://doi.org/10.4081/reumatismo.2010.51

  1638

  PDF: 842
• 

  Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study

  F. Ceccarelli, V. Covelli, G. Olivieri, F. Natalucci, C. Alessandri, F. Conti

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1491

  1372

  PDF: 654

• Reactive arthritis: advances in diagnosis and treatment

  C. Palazzi, I. Olivieri, C. Salvarani, E. D'Amico, G. Alleva, P. Vitullo, A. Petricca

  105-112

  https://doi.org/10.4081/reumatismo.2002.105

  1365

  PDF: 3447

• IMAGING OF PSORIATIC ARTHRITIS

  I. Olivieri, E. Scarano, A. Padula, S. D'Angelo

  73-76

  https://doi.org/10.4081/reumatismo.2007.1s.73

  1444

  PDF: 1176

• Therapy of rheumatic polymyalgia: the pathophysiologic management

  M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino

  271-279

  https://doi.org/10.4081/reumatismo.2007.271

  1672

  PDF: 2204